Dr. Neeraj Ramvishal
Overview
Neeraj Ramvishal is an Oncologist and a Hematologist in Raleigh, North Carolina. Dr. Ramvishal has been practicing medicine for over 39 years and is rated as an Experienced provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). His top areas of expertise are Familial Colorectal Cancer, Colorectal Cancer, Lynch Syndrome, and Pancreatoblastoma.
His clinical research consists of co-authoring 3 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- MEDICARE MAPD
- MEDICARE SNP
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- POS
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
3404 Wake Forest Rd, Raleigh, NC 27609
3404 Wake Forest Rd, Raleigh, NC 27609
Additional Areas of Focus
Dr. Ramvishal has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
University Of North Carolina At Chapel Hill
Sascha Tuchman is a Hematologist and an Oncologist in Chapel Hill, North Carolina. Dr. Tuchman is rated as an Elite provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). His top areas of expertise are Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Monoclonal Gammopathy of Undetermined Significance (MGUS), Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Tuchman is currently accepting new patients.
Duke Health Integrated Practice Inc
Robin Hardie is a Hematologist Oncology specialist and a Hematologist in Durham, North Carolina. Dr. Hardie has been practicing medicine for over 27 years and is rated as a Distinguished provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). Her top areas of expertise are Paget Disease of the Breast, Monoclonal Gammopathy of Undetermined Significance (MGUS), Familial Colorectal Cancer, and Colorectal Cancer.
Duke Adult Blood And Marrow Transplant Clinic
I treat patients with blood disorders and cancers, and I have a particular interest in helping patients with hematologic blood cancers, like leukemia, myeloma, and lymphoma, including the use of cellular therapies. I am fortunate to have a great team that works with me. We emphasize providing compassionate, individualized care using up-to-date, evidence-based treatments, including access to clinical trials. My patients are often going through a great deal, and I am devoted to their care. I have lived in this community for several decades and am honored to practice here. Dr. Ramalingam is rated as an Advanced provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). His top areas of expertise are Monoclonal Gammopathy of Undetermined Significance (MGUS), Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma, Schnitzler Syndrome, and Bone Marrow Transplant.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Colorectal CancerDr. Ramvishal isDistinguished. Learn about Colorectal Cancer.
- Familial Colorectal CancerDr. Ramvishal isDistinguished. Learn about Familial Colorectal Cancer.
- Familial Pancreatic CancerDr. Ramvishal isDistinguished. Learn about Familial Pancreatic Cancer.
- Lynch SyndromeDr. Ramvishal isDistinguished. Learn about Lynch Syndrome.
- Neuroendocrine TumorDr. Ramvishal isDistinguished. Learn about Neuroendocrine Tumor.
- Pancreatic CancerDr. Ramvishal isDistinguished. Learn about Pancreatic Cancer.
- Advanced
- Ampullary CancerDr. Ramvishal isAdvanced. Learn about Ampullary Cancer.
- AngiosarcomaDr. Ramvishal isAdvanced. Learn about Angiosarcoma.
- Breast CancerDr. Ramvishal isAdvanced. Learn about Breast Cancer.
- Cholangiocarcinoma (Bile Duct Cancer)Dr. Ramvishal isAdvanced. Learn about Cholangiocarcinoma (Bile Duct Cancer).
- Chronic B-Cell Leukemia (CBCL)Dr. Ramvishal isAdvanced. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Lymphocytic Leukemia (CLL)Dr. Ramvishal isAdvanced. Learn about Chronic Lymphocytic Leukemia (CLL).
- Experienced
- Acinic Cell Carcinoma of Salivary GlandsDr. Ramvishal isExperienced. Learn about Acinic Cell Carcinoma of Salivary Glands.
- Acute Lymphoblastic Leukemia (ALL)Dr. Ramvishal isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Myeloblastic Leukemia with MaturationDr. Ramvishal isExperienced. Learn about Acute Myeloblastic Leukemia with Maturation.
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Ramvishal isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Adenoid Cystic CarcinomaDr. Ramvishal isExperienced. Learn about Adenoid Cystic Carcinoma.